Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

SZSE:300760 Stock Report

Market Cap: CN¥273.2b

Shenzhen Mindray Bio-Medical Electronics Future Growth

Future criteria checks 2/6

Shenzhen Mindray Bio-Medical Electronics is forecast to grow earnings and revenue by 12.1% and 11.6% per annum respectively. EPS is expected to grow by 13.9% per annum. Return on equity is forecast to be 31.4% in 3 years.

Key information

12.1%

Earnings growth rate

13.92%

EPS growth rate

Medical Equipment earnings growth22.3%
Revenue growth rate11.6%
Future return on equity31.44%
Analyst coverage

Good

Last updated28 May 2025

Recent future growth updates

Recent updates

Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Has A Rock Solid Balance Sheet

Mar 24
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Has A Rock Solid Balance Sheet

The Trend Of High Returns At Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Has Us Very Interested

Mar 08
The Trend Of High Returns At Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Has Us Very Interested

Is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) Trading At A 44% Discount?

Feb 05
Is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) Trading At A 44% Discount?

There Is A Reason Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Price Is Undemanding

Jan 20
There Is A Reason Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Price Is Undemanding

Does Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Have A Healthy Balance Sheet?

Dec 03
Does Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Have A Healthy Balance Sheet?

We Like Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Returns And Here's How They're Trending

Nov 18
We Like Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Returns And Here's How They're Trending

Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation?

Oct 24
Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation?

Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Ticks All The Boxes When It Comes To Earnings Growth

Oct 08
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Ticks All The Boxes When It Comes To Earnings Growth

Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

Aug 12
Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns

Jul 28
Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns

Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

Jun 06
Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)

Earnings and Revenue Growth Forecasts

SZSE:300760 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202750,71416,09915,06617,47120
12/31/202646,54614,91613,00016,59827
12/31/202539,87012,56411,82214,02322
3/31/202535,59011,1379,00711,062N/A
12/31/202436,72611,66810,47312,432N/A
9/30/202437,11312,38512,24114,364N/A
6/30/202436,98712,70112,53815,075N/A
3/31/202435,94012,17110,02812,593N/A
12/31/202334,93211,5828,37311,062N/A
9/30/202334,37411,33910,58813,170N/A
6/30/202333,48610,76210,46012,547N/A
3/31/202331,78710,07310,50912,605N/A
1/1/202330,3669,60710,22612,141N/A
9/30/202229,1749,4417,9519,643N/A
6/30/202227,8478,9457,8969,552N/A
3/31/202226,4328,3927,2918,758N/A
1/1/202225,2708,0027,5968,999N/A
9/30/202124,3547,9577,6488,977N/A
6/30/202123,2407,5486,8288,184N/A
3/31/202122,0667,0597,2778,561N/A
12/31/202021,0266,6587,6878,870N/A
9/30/202020,2406,3736,3157,428N/A
6/30/202018,9155,7655,9036,832N/A
3/31/202017,3914,9884,8665,675N/A
12/31/201916,5564,6813,9454,722N/A
9/30/201915,8534,4944,0874,867N/A
6/30/201915,1514,2173,9394,628N/A
3/31/201914,4233,9183,4254,069N/A
12/31/201813,7533,719N/A4,035N/A
9/30/201813,1093,492N/A3,508N/A
12/31/201711,1742,589N/A3,300N/A
12/31/20169,0321,600N/A3,040N/A
12/31/20158,013910N/A2,024N/A
12/31/20147,8361,360N/A1,741N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300760's forecast earnings growth (12.1% per year) is above the savings rate (2.7%).

Earnings vs Market: 300760's earnings (12.1% per year) are forecast to grow slower than the CN market (23.3% per year).

High Growth Earnings: 300760's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300760's revenue (11.6% per year) is forecast to grow slower than the CN market (12.3% per year).

High Growth Revenue: 300760's revenue (11.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300760's Return on Equity is forecast to be high in 3 years time (31.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/30 09:51
End of Day Share Price 2025/05/30 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is covered by 46 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhe SunBofA Global Research
Zhishun SiuCCB International Securities Limited
Jingning LongChasing Securities